Literature DB >> 6786672

Influence of cimetidine on pharmacokinetics of propranolol.

A M Heagerty, M A Donovan, C M Castleden, J F Pohl, L Patel, A Hedges.   

Abstract

Whole-blood propranolol concentrations were estimated for 12 hours after a single 80 mg oral dose was given in six patients taking cimetidine and two weeks after they had stopped the drug. Mean blood propranolol concentrations were higher throughout the sampling period when the patients were taking cimetidine than when they were not, and the difference was statistically significant between one and four hours (p less than 0.05). The mean relative bioavailability of propranolol, measured as the area under the concentration time curve, was significantly higher when the patients were taking cimetidine (p less than 0.025). The mean increase in bioavailability was 136.5 +/- 57.6%, and the results were consistent in each subject. It is concluded from these results that cimetidine reduces the hepatic first-pass extraction of propranolol.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6786672      PMCID: PMC1505810          DOI: 10.1136/bmj.282.6280.1917

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  14 in total

1.  Altered drug binding due to the use of indwelling heparinized cannulas (heparin lock) for sampling.

Authors:  M Wood; D G Shand; A J Wood
Journal:  Clin Pharmacol Ther       Date:  1979-01       Impact factor: 6.875

2.  Cimetidine inhibits microsomal drug metabolism in the rat.

Authors:  J Puurunen; O Pelkonen
Journal:  Eur J Pharmacol       Date:  1979-05-01       Impact factor: 4.432

3.  Effects of age and cigarette smoking on propranolol disposition.

Authors:  R E Vestal; A J Wood; R A Branch; D G Shand; G R Wilkinson
Journal:  Clin Pharmacol Ther       Date:  1979-07       Impact factor: 6.875

4.  Pharmacokinetics of oral propranolol in chronic renal disease.

Authors:  D T Lowenthal; W A Briggs; T P Gibson; H Nelson; W J Cirksena
Journal:  Clin Pharmacol Ther       Date:  1974-11       Impact factor: 6.875

5.  Delayed clearance of diazepam due to cimetidine.

Authors:  U Klotz; I Reimann
Journal:  N Engl J Med       Date:  1980-05-01       Impact factor: 91.245

6.  The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration.

Authors:  A J Wood; D M Kornhauser; G R Wilkinson; D G Shand; R A Branch
Journal:  Clin Pharmacokinet       Date:  1978 Nov-Dec       Impact factor: 6.447

7.  High-pressure liquid chromatographic determination of cimetidine sulphoxide in human blood and urine.

Authors:  R M Lee; P M Osborne
Journal:  J Chromatogr       Date:  1978-09-01

8.  Contribution of individual differences in gastric emptying to variability in plasma propranolol concentrations.

Authors:  C M Castleden; C F George; M D Short
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

9.  Cimetidine impairs elimination of chlordiazepoxide (Librium) in man.

Authors:  P V Desmond; R V Patwardhan; S Schenker; K V Speeg
Journal:  Ann Intern Med       Date:  1980-08       Impact factor: 25.391

10.  Cimetidine: interaction with oral anticoagulants in man.

Authors:  M J Serlin; R G Sibeon; S Mossman; A M Breckenridge; J R Williams; J L Atwood; J M Willoughby
Journal:  Lancet       Date:  1979-08-18       Impact factor: 79.321

View more
  39 in total

Review 1.  beta-blockers. Drug interactions of clinical significance.

Authors:  I Blaufarb; T M Pfeifer; W H Frishman
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

2.  Drug interactions through binding to cytochrome p 450: the experience with h2-receptor blocking agents.

Authors:  U Klotz; I W Reimann
Journal:  Pharm Res       Date:  1984-03       Impact factor: 4.200

Review 3.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

4.  Drug interactions and beta blockers.

Authors:  L Beeley
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-17

5.  H2 receptor antagonists: cimetidine and ranitidine.

Authors:  J R Wood
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-30

6.  Variability of beta-blocker pharmacokinetics in young volunteers.

Authors:  D B Jack; C P Quarterman; R Zaman; M J Kendall
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Failure of ranitidine to interact with propranolol.

Authors:  A M Heagerty; C M Castleden; L Patel
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-01

8.  The effect of pretreatment with cimetidine on the bioavailability and disposition of atenolol and metoprolol.

Authors:  J J Houtzagers; O Streurman; C G Regårdh
Journal:  Br J Clin Pharmacol       Date:  1982-07       Impact factor: 4.335

9.  Propranolol pharmacokinetics during the menstrual cycle.

Authors:  I Abdu-Aguye; D Dunlop; P Patel; P Turner
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

10.  Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.

Authors:  D Gangji; M Juvent; G Niset; M Wathieu; M Degreve; R Bellens; J Poortmans; S Degre; T J Fitzsimons; A Herchuelz
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.